XML 22 R11.htm IDEA: XBRL DOCUMENT v3.22.2.2
Financial Instruments
 6 Months Ended
Jun. 30, 2022
Investments, Debt and Equity Securities [Abstract]  
Financial Instruments

4. Financial Instruments

Cash equivalents, all of which are classified as available-for-sale securities, and restricted cash, consisted of the following (in thousands):

 

 

June 30, 2022

 

 

December 31, 2021

 

 

Cost

 

 

Unrealized Gain

 

 

Unrealized (Loss)

 

 

Estimated Fair Value

 

 

Cost

 

 

Unrealized Gain

 

 

Unrealized (Loss)

 

 

Estimated Fair Value

 

Money market funds

$

41,201

 

 

$

—

 

 

$

—

 

 

$

41,201

 

 

$

56,337

 

 

$

—

 

 

$

—

 

 

$

56,337

 

 

$

41,201

 

 

$

—

 

 

$

—

 

 

$

41,201

 

 

$

56,337

 

 

$

—

 

 

$

—

 

 

$

56,337

 

Classified as:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents

 

 

 

 

 

 

 

 

 

$

40,931

 

 

 

 

 

 

 

 

 

 

 

$

56,067

 

Restricted cash

 

 

 

 

 

 

 

 

 

 

270

 

 

 

 

 

 

 

 

 

 

 

 

270

 

Total cash equivalents,
   restricted cash and
   investments

 

 

 

 

 

 

 

 

 

$

41,201

 

 

 

 

 

 

 

 

 

 

 

$

56,337

 

There have been no significant realized gains or losses on available-for-sale securities for the periods presented. As of June 30, 2022 and December 31, 2021, there were no unrealized losses on cash equivalents. As of June 30, 2022, the Company had a total of $42.1 million in cash, cash equivalents and restricted cash, which includes approximately $0.9 million in cash and $41.2 million in cash equivalents and restricted cash.